Lynn E. Heasley

11.1k citations
141 papers · 9.2k · 2 hit papers · h-index 50

Impact in

  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Protein Kinase Regulation and GTPase Signaling
    • Melanoma and MAPK Pathways
    • Fibroblast Growth Factor Research
    • PI3K/AKT/mTOR signaling in cancer
    • Receptor Mechanisms and Signaling

Papers in

    • Protein Kinase Regulation and GTPase Signaling 30
    • Fibroblast Growth Factor Research 19
    • PI3K/AKT/mTOR signaling in cancer 18
    • Melanoma and MAPK Pathways 14
    • Cancer-related gene regulation 10
    • Receptor Mechanisms and Signaling 9
    • Cancer Immunotherapy and Biomarkers 15

Lynn E. Heasley

140 papers receiving 9.0k citations

Lynn E. Heasley's Hit Papers

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer 2012 · 820 citations
8200+8+17Years since publication250500750

Peers

Lynn E. Heasley
Comparison fields: 5 of 127
  • Oncology 2.7k
  • Molecular Biology 6.0k
  • Cancer Research 1.3k
  • Immunology 1.2k
  • Pulmonary and Respiratory Medicine 1.8k
Replace Vuk Stambolic with:
Vuk Stambolic Canada
Carol A. Lange United States
Darren A.E. Cross United Kingdom
Andrew S. Kraft United States
Jiping Zha United States
Amancio Carnero Spain
Robert J. Matusik United States
József Tı́már Hungary
Alfonso Bellacosa United States
Markus Wartmann Switzerland
Lynn E. Heasley relative to Vuk Stambolic Canada Vuk Stambolic's profile →
Citations per field
00.5×3.5×
Vuk Stambolic · 1×
Citations per year

Countries citing papers authored by Lynn E. Heasley

Since Specialization
Citations

This map shows the geographic impact of Lynn E. Heasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. Heasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. Heasley more than expected).

Fields of papers citing papers by Lynn E. Heasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. Heasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. Heasley. The network helps show where Lynn E. Heasley may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynn E. Heasley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynn E. Heasley Line = papers co-authored together Lynn E. Heasley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Hit paper breakdown →
2012820
2
Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein
Hit paper breakdown →
2000697
3 1993471
4 2018209
5 1989207
6 1992204
7 2013203
8 2008180
9 2001170
10 2012170
11 1995168
12 1995167
13
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
1999167
14 1997145
15 1997144
16 2005140
17 1992130
18 2017128
19 2014125
20 2002125

About Lynn E. Heasley

Lynn E. Heasley is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 141 papers that have together received 9.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Protein Kinase Regulation and GTPase Signaling (30 papers), Fibroblast Growth Factor Research (19 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Cancer Immunotherapy and Biomarkers (15 papers), Melanoma and MAPK Pathways (14 papers), Cancer-related gene regulation (10 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Oncology (2.7k citations), Molecular Biology (6.0k citations), Cancer Research (1.3k citations), Immunology (1.2k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Lynn E. Heasley has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Gary L. Johnson, Raphael A. Nemenoff, Raphael A. Nemenoff, Sunil Gupta, Robert C. Doebele, Lindsay A. Marek, Vicki Van Putten, Laura Butterfield, Wilbur A. Franklin and Carol L. Sable. Their work appears in journals such as Journal of Biological Chemistry, Molecular Pharmacology, Cancer Research, Molecular and Cellular Biology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact